Researchers have confirmed for the first time the benefit of an innate defense system present in the few patients who remain healthy after years of infection with HIV despite receiving no treatment, according to an article published in the September edition of the Journal of Virology. The study found that the subset of HIV-infected patients referred to as long-term survivors or nonprogressors have higher amounts of a key enzyme in their white blood cells. At the same time, a related biotech company is poised to begin preclinical testing on a drug designed to confer similar protection on most HIV patients.
Study holds promise for new way to fight HIV
- ► 2013 (23)
- ► 2008 (24)
- ► 2007 (65)
- ► 2006 (77)
- Wall Street Caves in to Anti-Science Terrorists
- The "Postive" Era of Gentically Modified Foods is...
- China promotes new typing reagent for leukemia
- New kind of health care is coming, says acting FDA...
- Possible Conflicts for Doctors Are Seen on Medical...
- Thomas Tuschl's groundbreaking work in the field o...
- Elan & Biogen plan relaunch of Tysabri
- Gene that controls the severity of asthma identifi...
- Study: Medical Research Spending Jumps
- New Orleans' Health System Faces Crisis
- Market forces block tailored medicines, says exper...
- Scientists Find Genetic Clues in Fanconi Anemia
- Glowing Mice - Jumping Genes
- Exiled from their La. labs, scientists assess thei...
- Super Bug
- Calif.'s Stem Cell Agency Awards Grants
- New Technique Tracks Stem Cells' Progress
- Study holds promise for new way to fight HIV
- Breast Cancer Risk Increased for African Americans...
- ▼ September (19)